A common way to demonstrate that tumor-specific CD8+ T cells have been generated is to demonstrate that a bolus of tumor cells injected at least 2 weeks after the primary tumor has been treated fails to grow into a tumor due to CD8+ T cell infiltration. This evidence concerns the gene CD8A and neoplasm.